Antibody array profiling reveals serum TSP‐1 as a marker to distinguish benign from malignant prostatic disease

Antibody array profiling reveals serum TSP‐1 as a marker to distinguish benign from malignant prostatic disease
复制标题

DOI：
10.1002/pros.20514
复制
发表时间：
2007-02
期刊：
The Prostate
影响因子：
--
通讯作者：
Michael W. Shafer;L. Mangold;A. Partin;B. Haab
Michael W. Shafer;L. Mangold;A. Partin;B. Haab
中科院分区：
其他
文献类型：
--
作者：
Michael W. Shafer;L. Mangold;A. Partin;B. Haab

文献摘要

被引文献

相似文献

提供更准确或更早诊断前列腺癌的血液蛋白标志物应该对前列腺癌的治疗和管理产生积极影响。
Blood protein markers that provide more accurate or earlier diagnosis of prostate cancer should have a positive impact on prostate cancer treatment and management.